易瑞生物: 关于股东减持股份计划期间届满暨实施情况的公告

Group 1 - The company disclosed a reduction in shareholding by shareholder Wang Tianyi, who plans to sell 12,026,005 shares, representing 3.0000% of the total share capital, within three months starting from April 2025 [1][2] - Wang Tianyi's shareholding decreased to below 5% after the reduction, meaning he is no longer a major shareholder [1][2] - The total shares reduced by Wang Tianyi amounted to 6,337,700 shares, with an average selling price of 9.29 yuan per share for 3,990,100 shares sold through centralized bidding and 8.43 yuan per share for 2,347,600 shares sold through block trading [1][2] Group 2 - Before the reduction, Wang Tianyi held 26,403,521 shares, accounting for 6.579207% of the total share capital, which decreased to 20,065,821 shares, or 4.999984% after the reduction [2] - The actual number of shares reduced did not exceed the planned reduction, and the reduction will not lead to a change in the company's control [2]